| Human origins in a southern African palaeo-wetland and first migrations EKF Chan, A Timmermann, BF Baldi, AE Moore, RJ Lyons, SS Lee, ... Nature 575 (7781), 185-189, 2019 | 167 | 2019 |
| Focal irreversible electroporation as primary treatment for localized prostate cancer W van den Bos, MJ Scheltema, AR Siriwardana, AMF Kalsbeek, ... BJU international 121 (5), 716-724, 2018 | 115 | 2018 |
| C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer ES Martens-Uzunova, Y Hoogstrate, A Kalsbeek, B Pigmans, ... Oncotarget 6 (19), 17430, 2015 | 98 | 2015 |
| Whole-genome sequencing reveals elevated tumor mutational burden and initiating driver mutations in African men with treatment-naïve, high-risk prostate cancer W Jaratlerdsiri, EKF Chan, T Gong, DC Petersen, AMF Kalsbeek, ... Cancer research 78 (24), 6736-6746, 2018 | 85 | 2018 |
| Initial multicentre experience of 68gallium‐PSMA PET/CT guided robot‐assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit … A Siriwardana, J Thompson, PJ van Leeuwen, S Doig, A Kalsbeek, ... BJU international 120 (5), 673-681, 2017 | 73 | 2017 |
| Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy MJ Scheltema, JI Chang, M Böhm, W van den Bos, A Blazevski, ... World Journal of Urology 36, 1383-1389, 2018 | 41 | 2018 |
| Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management AMF Kalsbeek, EKF Chan, NM Corcoran, CM Hovens, VM Hayes Oncotarget 8 (41), 71342, 2017 | 40 | 2017 |
| Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio‐recurrent prostate cancer MJ Scheltema, W van den Bos, AR Siriwardana, AMF Kalsbeek, ... BJU international 120, 51-58, 2017 | 37 | 2017 |
| The Evx1/Evx1as gene locus regulates anterior-posterior patterning during gastrulation CC Bell, PP Amaral, A Kalsbeek, GW Magor, KR Gillinder, P Tangermann, ... Scientific reports 6 (1), 26657, 2016 | 33 | 2016 |
| Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer AMF Kalsbeek, EFK Chan, J Grogan, DC Petersen, W Jaratlerdsiri, ... Aging (Albany NY) 8 (11), 2702, 2016 | 31 | 2016 |
| Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer AMF Kalsbeek, EKF Chan, J Grogan, DC Petersen, W Jaratlerdsiri, ... The Prostate 78 (1), 25-31, 2018 | 23 | 2018 |
| The impact of whole genome data on therapeutic decision-making in metastatic prostate cancer: a retrospective analysis M Crumbaker, EKF Chan, T Gong, N Corcoran, W Jaratlerdsiri, RJ Lyons, ... Cancers 12 (5), 1178, 2020 | 14 | 2020 |
| Author Correction: Human origins in a southern African palaeo-wetland and first migrations EKF Chan, A Timmermann, BF Baldi, AE Moore, RJ Lyons, SS Lee, ... Nature 592 (7852), E7-E7, 2021 | 1 | 2021 |
| The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis W Jaratlerdsiri, RJ Lyons, AM Haynes, AA Kulidjian, AMF Kalsbeek, ... Urological Cancer 2020, 67, 2021 | | 2021 |
| Human origins in a southern African palaeo-wetland and first migrations (vol 575, pg 185, 2019) EKF Chan, A Timmermann, BF Baldi, AE Moore, RJ Lyons, SS Lee, ... NATURE, 2021 | | 2021 |
| HIGH-GRADE PROSTATE CANCER HAS INCREASED MITOCHONDRIAL CONTENT: MP83-01 A Kalsbeek, E Chan, J Grogan, D Petersen, W Jaratlerdsiri, R Gupta, ... Journal of Urology 197 (4), e1105-e1106, 2017 | | 2017 |
| ROBOT-ASSISTED SALVAGE NODE DISSECTION FOR OLIGOMETASTATIC NODAL DISEASE DETECTED BY 68GALLIUM-PSMA PET/CT: A MULTICENTRE RETROSPECTIVE SERIES: MP53-10 A Siriwardana, J Thompson, S Doig, P van Leeuwen, A Kalsbeek, ... Journal of Urology 197 (4), e716-e717, 2017 | | 2017 |
| Focal Irreversible Electroporation (IRE) as a primary and salvage treatment for localised prostate cancer A Siriwardana, W Van den Bos, A Kalsbeek, J Thompson, F Ting, M Bohm, ... BJU INTERNATIONAL 119, 37-38, 2017 | | 2017 |
| Mitochondrial genome variation and prostate cancer: A review of the mutational landscape and application to clinical management V Hayes, EKF Chan, NM Corcoran, CM Hovens, A Kalsbeek Impact Journals LLC, 2017 | | 2017 |
| The mitochondrial genome as a biomarker for prostate cancer A Kalsbeek UNSW Sydney, 2017 | | 2017 |
